More articles from Epigenetics

BAP1 Loss Transforms Mesothelioma Cells in an EZH2-Dependent Manner
Cancer Discovery Dec 2015, 5 (12) OF9; DOI: 10.1158/2159-8290.CD-RW2015-195
Epigenetic Silencing of T_H1-Type Chemokines Promotes Tumor Immune Evasion
Cancer Discovery Dec 2015, 5 (12) 1237; DOI: 10.1158/2159-8290.CD-RW2015-209
H3K36me3-Deficient Cancers Are Sensitive to WEE1 Kinase Inhibition
Cancer Discovery Dec 2015, 5 (12) 1233; DOI: 10.1158/2159-8290.CD-RW2015-210
A Broad H3K4me3 Signature Enriches for Tumor-Suppressor Genes
Cancer Discovery Nov 2015, 5 (11) OF9; DOI: 10.1158/2159-8290.CD-RW2015-166
Combination Therapy with the Epigenetic Drugs JQ1 and SAHA Inhibits PDAC
Cancer Discovery Nov 2015, 5 (11) 1119; DOI: 10.1158/2159-8290.CD-RW2015-186
The Global H3K4 Methylation State Controls Leukemia Stem Cell Fate
Cancer Discovery Sep 2015, 5 (9) 902; DOI: 10.1158/2159-8290.CD-RW2015-140
SIRT1 Mediates the Effects of DOT1L Inhibition in MLL-Rearranged Leukemia
Cancer Discovery Jun 2015, 5 (6) OF12; DOI: 10.1158/2159-8290.CD-RW2015-069
Super-Enhancers Facilitate Gene Regulation by Signaling Pathways
Cancer Discovery May 2015, 5 (5) OF11; DOI: 10.1158/2159-8290.CD-RW2015-056
ARID1A-Mutated Cancers Are Sensitive to EZH2 Methyltransferase Inhibition
Cancer Discovery Apr 2015, 5 (4) OF6; DOI: 10.1158/2159-8290.CD-RW2015-034
The Transcription Factor WT1 Regulates Sequence-Specific TET2 Binding
Cancer Discovery Mar 2015, 5 (3) OF6; DOI: 10.1158/2159-8290.CD-RW2015-013

Main menu